Acerca de la compañía

At Forge Therapeutics, we are developing novel antibiotics targeting bacterial metalloenzymes. As bacteria become more and more resistant to conventional antibiotics, common medical procedures such as surgery, chemotherapy, and dialysis become increasingly risky.

US
Desconocido
Empresa no verificada